Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indrayani BiotechBOM:526445 +5.95%53 PB Ratio is 0.52 as of Aug. 09, 2026, which is 84% below its 10-year median of 3.24. GuruFocus rates BOM:526445 with a GF Score™ of 53/100 and a GF Value™ of ₹41.52 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,043 Business Services companies, Indrayani Biotech ranks better than 89.45% on this metric.
Indrayani Biotech Ltd stock PB Ratio (=0.52) is close to 5-year low of 0.52.
The historical rank and industry rank for Indrayani Biotech's PB Ratio or its related term are showing as below:
BOM:526445'
s PB Ratio Range Over the Past 10 Years
Min: 0.09 Med: 3.24 Max: 6.66
Current: 0.52
During the past 13 years, Indrayani Biotech's highest PB Ratio was 6.66. The lowest was 0.09. And the median was 3.24.
BOM:526445's PB Ratio is ranked better than 89.45% of 1043
companies
in the Business Services industry
Industry Median: 1.67
vs BOM:526445: 0.52
During the past 12 months, Indrayani Biotech's average Book Value Per Share Growth Rate was 1.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 31.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -12.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Indrayani Biotech was 36.80% per year. The lowest was -42.50% per year. And the median was 5.25% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Indrayani Biotech PB Ratio Related Terms
Indrayani Biotech PB Ratio Historical Data
* Premium members only.
The historical data trend for Indrayani Biotech's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526445 vs CTAS, CPRT, GPN: PB Ratio Comparison
For the Specialty Business Services subindustry, Indrayani Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indrayani Biotech PB Ratio vs Business Services Industry
For the Business Services industry and Industrials sector, Indrayani Biotech's PB Ratio distribution charts can be found below:
* The bar in red indicates where Indrayani Biotech's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Indrayani Biotech (BOM:526445) has a PB Ratio of 0.52 as of Aug. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Indrayani Biotech and its competitors. This is 84% below median its historical median of 3.24. Over the past decade, Indrayani Biotech's PB Ratio has ranged from 0.09 to 6.66. According to the industry distribution chart, Indrayani Biotech ranks #110 out of 1043 companies in the Business Services industry, placing it in the top 10.5%.
Is Indrayani Biotech's PB Ratio too high?
Indrayani Biotech's current PB Ratio of 0.52 is 84% below median its 10-year median of 3.24. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 6.66. The Business Services industry median PB Ratio is 1.67. Indrayani Biotech's value of 0.52 is 68.9% below this industry median. Based on the distribution chart, Indrayani Biotech ranks #110 out of 1043 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, Indrayani Biotech has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's PB Ratio compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Indrayani Biotech ranks #110 out of 1043 companies for PB Ratio. This places Indrayani Biotech in the top 11% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.67. Indrayani Biotech's value of 0.52 is 68.9% below this benchmark. Historically, Indrayani Biotech's own PB Ratio has ranged from 0.09 to 6.66 over the past decade. While the company's 10-year median is 3.24 vs. the industry median of 1.67, Indrayani Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Business Services company?
The median PB Ratio among Business Services companies is 1.67, based on 1,043 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indrayani Biotech's current PB Ratio of 0.52 is 68.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Indrayani Biotech and its competitors. For the Business Services industry, the median PB Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indrayani Biotech's current PB Ratio is 0.52, which is 84% below median its own 10-year median of 3.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.52, compared to a current price of ₹8.72 — trading 79% below its estimated fair value. The current PB Ratio is 0.52, which is 84% below median its 10-year median of 3.24 and 68.9% below the Business Services industry median of 1.67. Indrayani Biotech's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current PB Ratio is 0.52 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indrayani Biotech (BOM:526445) Overvalued in 2026?
Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued.
The current stock price of ₹8.72 is trading 79% below its estimated GF Value™ of ₹41.52.
GuruFocus considers Indrayani Biotech to be Possible Value Trap.
Key valuation signals for BOM:526445:
PB Ratio: 0.52 (84% below median its 10-year median of 3.24)
GF Value™: ₹41.52 vs. price of ₹8.72 (79% below fair value)
Industry Position: 68.9% below the Business Services median (#110 of 1043)
No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
53GF Score
Get the complete analysis for BOM:526445
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526445 has been successfully added to your 
